Home/ Supplements/ Vitamin A/ Vita-Min

Vita-Min

product on market Capsule Bio-Tech Pharmacal Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 70% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains vitamins A, C, D3, E, and K, which are supported by strong evidence for maintaining immune function and bone health. These essential nutrients play critical roles in cellular protection and coagulation. The ingredient profile is backed by extensive research, though overall evidence coverage for this specific blend is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for Vita-Min
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Other Combinations
Product Type
70%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
5000 IU (100% DV)
Vitamin C
100 mg (167% DV)
2000 IU (500% DV)
3.3× RDA — above typical dose (UL: 0.1 mg) 608 studies (A:16, B:251)
80 IU (267% DV)
3.6× RDA — above typical dose (UL: 1000 mg) 179 studies (A:3, B:90)
205 mcg (256% DV)
1.7× RDA — within safe limits 275 studies (A:9, B:175)
25 mg (1667% DV)
20.8× RDA — above typical dose 76 studies (A:0, B:33)
25 mg (1471% DV)
19.2× RDA — above typical dose 13 studies (A:0, B:1)
25 mg (125% DV)
1.8× RDA — within safe limits 196 studies (A:5, B:63)
25 mg (1250% DV)
19.2× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
800 mcg (200% DV)
2.0× RDA — within safe limits 226 studies (A:10, B:105)
200 mcg (3333% DV)
83.3× RDA — above typical dose 139 studies (A:1, B:44)
500 mcg (167% DV)
16.7× RDA — above typical dose 27 studies (A:0, B:11)
25 mg (250% DV)
5.0× RDA — above typical dose 2 studies — no high-quality reviews
200 mcg (133% DV)
1.3× RDA — within safe limits 245 studies (A:4, B:133)
15 mg (4% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
15 mg (100% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)
100 mcg (143% DV)
1.8× RDA — within safe limits 173 studies (A:0, B:67)
0.05 mg (3% DV)
Within RDA (0.1× RDA) 37 studies (A:0, B:11)
0.2 mg (10% DV)
Within RDA (0.1× RDA) 9 studies — no high-quality reviews
200 mcg (167% DV)
5.7× RDA — above typical dose 199 studies (A:1, B:55)
200 mcg (267% DV)
4.4× RDA — above typical dose (UL: 2 mg) 3 studies — no high-quality reviews
Potassium
10 mg (1% DV)
Proprietary Complex
50 mg

Other Ingredients

Gelatin Capsule Dicalcium Phosphate Maltodextrin
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: One capsule per day or as directed by a healthcare professional. Individuals taking blood-thinning medications should consult a healthcare professional.

Warnings & Precautions

Keep out of the reach of children.

Safety sealed for your protection.

Contains corn and soy.

Individuals taking blood-thinning medications should consult a healthcare professional.

Formulation Notes

Contains No: Dairy, egg, fish, shellfish, nuts, wheat, gluten, sugar, yeast or artificial colors.

Halal certified.

GMP Good Manufacturing Practice

Additional Information

Store tightly closed in a cool, dry place.

Energy = Health

GMP Good Manufacturing Practice

ISWA Halal

Made in the USA

PNR Over 100 Partners in Research

Metadata

Product Details

UPC / SKU7 05105 11140 7
DSLD Entry Date2020-04-23
Product TypeOther Combinations
FormCapsule
DSLD ID217132
Data Updated2026-04-11
Research

Research Evidence

337
Research Sources
54
Avg Quality
161
Meta Analysis
68
Systematic Review
51
Rct
48
Clinical Trial
2
Other
2
Regulatory Source
1
Narrative Review
1
Cochrane Review
1
Guideline
1
Openfda Safety
A Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis
Meta Analysis BMJ (Clinical research ed.) 2011 PubMed DOI
A Fortification of staple foods with vitamin A for vitamin A deficiency
Systematic Review The Cochrane database of systematic reviews 2019 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
Narrative Review The Cochrane database of systematic reviews 2016 PubMed DOI
A Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of sport and health science 2023 PubMed DOI
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
View all evidence for Vitamin A →
Compare

Similar Products

View all Vitamin A products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.